Study of the Role of Genetic Modifiers in Hemoglobinopathies
Study of the Role of Genetic Modifiers in Hemoglobinopathies
Phase
Not reported
Enrollment
30000 (est.)
Age range
2 Years to —
Sex
ALL
Summary
This study will investigate the role of genetic modifiers in hemoglobinopathies through a large-scale, multi-ethnic genome-wide association study (GWAS).
Conditions studied
Sign-up window
Oct 1, 2022 – est. completion Sep 30, 2027
Sponsors
Study locations
Boston Children's Hospital
Boston, Massachusetts
Lucrecia Paím Maternity
Luanda
University of Buenos Aires
Buenos Aires
University Hospitals Leuven
Leuven
Universiti Brunei Darussalam
Brunei
Larnaca General Hospital
Larnaca
Limassol General Hospital
Limassol
Archbishop Makarios III Hospital
Nicosia
Paphos General Hospital
Paphos
Centre Hospitalier Monkole
Kinshasa
Rigshospitalet
Copenhagen
Hippokrateio Hospital of Athens
Athens
Laiko General Hospital
Athens
National and Kapodistrian University of Athens
Athens
General Hospital of Larissa
Larissa
Emek Medical Centre
Afula
University of Turin
Turin
Ampang Hospital
Ampang
Universiti Kebangsaan Malaysia
Bangi
Universiti Sains Malaysia
Kota Bharu
University of Abuja
Abuja
Kaduna State University
Kaduna
Ahmadu Bello University
Zaria
University of Lahore
Lahore
Centro Hospitalar e Universitário de Coimbra
Coimbra
Hospital Clínico San Carlos
Madrid